Table 1

Demographics and baseline clinical data (intention to treat population)

Treatment
Group, n=22
Control
Group, n=26
Female9 (40.9)15 (57.7)
Age in years, median (IQR)46 (18)52 (13)
Heartburn22 (100)24 (92.3)
Regurgitation20 (90.9)22 (84.6)
Chest pain6 (27.3)4 (15.4)
LPR symptoms8 (36.4)14 (53.8)
Dysphagia15 (68.2)15 (57.7)
PPI standard dose/once daily6 (27.3)4 (15.4)
PPI standard dose/twice daily3 (13.6)2 (7.7)
PPI max dose/once daily8 (36.4)12 (46.2)
PPI max dose/twice daily5 (22.7)8 (30.8)
PPI response—good10 (45.5)6 (23.1)
PPI response—partial7 (31.8)11 (42.3)
PPI response—poor5 (22.7)9 (34.6)
Manometric hiatus hernia8 (36.4)7 (26.9)
Oesophagitis grade A/B5 (22.7)7 (26.9)
  • Values are expressed as numbers (percentages) unless stated otherwise.

  • LPR, laryngopharyngeal reflux; PPI, proton pump inhibitor.